132,000 Melanoma Cases Yearly Push Scientists to Decode DNA’s Hidden Cure

World

As Turkey’s Cancer Battle Week concludes, a leading U.S. nuclear medicine specialist points to genetic research as the most promising path toward a cure, with particular focus on melanoma, the deadliest skin cancer.

Esma Akin, who leads nuclear medicine at George Washington University Medical Center in Washington DC, warns that no one escapes risk from this disease. Sun exposure remains a decisive factor in triggering melanoma, she explains.

“Everybody is under the risk of melanoma,” Akin said, noting that researchers believe the answer lies in decoding genetic material.

When ultraviolet light strikes skin cells, it damages a specific DNA protein. That damage causes cells to divide uncontrollably. They grow but fail to die off, multiplying instead of following normal life cycles.

Akin told Anadolu Agency that scientists now hunt for ways to interrupt this process. “We’re researching ways to prevent this and this is hidden in the genetic codes,” she said.

Geography and skin pigmentation influence individual risk levels. People with darker skin in certain regions face lower thresholds for melanoma because their cellular genetics adapted to sunlight during childhood, according to Akin.

Worldwide, roughly 132,000 new melanoma cases emerge annually, according to World Health Organization figures. The American Cancer Society identifies melanoma as the least common yet most lethal form of skin cancer.

Despite decades of global research, no universal cure exists. However, Akin says some of the most advanced current work examines genetics for better treatments.

“The human body is full of genetic codes and we are attempting to decipher these,” she explained. Once decoded, that knowledge could apply to any patient and block the disease from spreading.

Meanwhile, doctors deploy innovative techniques today. For liver cancer, radioembolization places radioactive beads directly into the organ to destroy defective cells.

Yet Akin stresses that halting cell division represents the critical breakthrough. “This is hidden within the genetic code,” she repeated.

Environmental factors add urgency. The ozone layer continues eroding, contributing to rising melanoma cases in recent years. A Yale University study predicts increased ultraviolet radiation concentrations globally if that trend persists.

National Cancer Institute data shows melanoma patients worldwide grew from about 1.5 million in 1992 to roughly 2 million in 2012. Lung, colon, breast, and prostate cancer diagnoses rose too, though Akin cautions those statistics partly reflect earlier detection rather than true increases.

Lung cancer remains the most common cancer worldwide. Akin advises avoiding tobacco, preventing infection, maintaining a healthy diet, and exercising to reduce overall cancer risk.